[Congressional Record Volume 164, Number 140 (Wednesday, August 22, 2018)]
[Senate]
[Page S5862]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3998. Mr. RUBIO submitted an amendment intended to be proposed to 
amendment SA 3695 proposed by Mr. Shelby to the bill H.R. 6157, making 
appropriations for the Department of Defense for the fiscal year ending 
September 30, 2019, and for other purposes; which was ordered to lie on 
the table; as follows:

       At the appropriate place in title II of division B, insert 
     the following:
       Sec. ___.  Not later than 90 days after the enactment of 
     this Act, the Secretary of Health and Human Services shall 
     submit a report to the Committee on Appropriations and the 
     Committee on Finance of the Senate and the Committee on 
     Appropriations and the Committee on Ways and Means of the 
     House of Representatives, detailing the circumstances in 
     which the Centers for Medicare & Medicaid Services may be 
     providing Medicare or Medicaid payments to, or otherwise 
     funding, entities that process genome or exome data in the 
     People's Republic of China or the Russian Federation. The 
     report shall outline the extent to which payments or other 
     funding have been provided to such entities over the past 5 
     years, including amounts paid to each entity, the 
     implications of such payments, including vulnerabilities, and 
     specific recommendations on steps to ensure that payments are 
     lawful and appropriate in the future. In developing the 
     report, the Secretary shall also coordinate with other 
     relevant agencies, as determined by the Secretary, to examine 
     the potential effect of allowing beneficiaries' genome or 
     exome data to be processed in the People's Republic of China 
     or the Russian Federation on United States national security, 
     United States intellectual property protections, HIPAA 
     privacy protections, future biomedical development 
     capabilities and competitiveness, and global competitiveness 
     for United States laboratories.
                                 ______